Caplin Point Labs zooms over 40% in six days on strong Q4 results

The stock hit a new high of Rs 5784, rallied 41% in past six trading sessions from Rs 406 on May 10

Caplin Point Laboratories hit new high of Rs 574, up 7% on BSE in otherwise weak market, extending its past one week rally, after the company reported more than doubled  consolidated net profit of Rs 33 crore in March quarter (Q4FY17), on the back of strong revenue growth. The pharmaceutical company had reported profit of Rs 16 crore in the same quarter a year ago.

Gross revenues during the quarter under review increased by 47% to Rs 121 crore against Rs 82 crore in the corresponding quarter of previous fiscal. Earnings before interest, tax, depreciation and amortization (EBITDA) margin